硒治疗恰加斯心肌病(STCC)试验方案更新
STCC试验旨在评估硒治疗对恰加斯心肌病患者心脏病进展的预防效果。方案更新包括:主要结局限制为左心室射血分数(连续变量),随访期从5年缩短至1年,年龄上限从65岁提高至75岁,糖尿病不再作为排除标准。
要点
- 主要结局改为左心室射血分数连续变量,排除疾病进展。
- 随访期从5年缩短至1年,可能提高参与率。
- 年龄上限提高至75岁,糖尿病不再排除。
核心结论
- 为保持试验可行性,对STCC试验方案进行了多项修改。
研究设计与样本
- STCC试验是一项评估硒治疗对恰加斯心肌病患者心脏病进展预防效果的临床试验。
主要发现
- 约三分之一的慢性恰加斯病患者出现心脏受累。
- 恰加斯心脏病患者的主要死亡机制为心力衰竭、猝死和心源性栓塞性卒中。
- 有症状的恰加斯心脏病患者血清硒水平低于无恰加斯心脏病患者。
- 动物模型显示补硒具有 promising 结果。
关键数值与推荐
- 主要结局限制为左心室射血分数作为连续变量,排除疾病进展。
- 随访期从5年缩短至1年。
- 年龄上限从65岁提高至75岁。
- 糖尿病不再作为排除标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Several studies evaluating clinical forms of chronic Chagas disease show that about one-third of patients present cardiac involvement. Heart failure, sudden death and cardioembolic stroke are the main mechanisms of death in Chagas heart disease. The impact of specific etiologic treatment on the prognosis of patients with chronic Chagas heart disease is very limited regardless of the presence or absence of heart failure. Patients with symptomatic Chagas heart disease present serum selenium (Se) levels lower than patients without Chagas heart disease. Moreover, Se supplementation in animal models showed promising results. The aim of this trial is to estimate the effect of Se treatment on prevention of heart disease progression in patients with Chagas cardiomyopathy. However, we had to introduce some protocol modifications in order to keep trial feasibility, as follows: the primary outcome was restricted to left ventricular ejection fraction as a continuous variable, excluding disease progression; the follow-up period was decreased from 5 years to 1 year, an adjustment that might increase the participation rate of our study; the superior age limit was increased from 65 to 75 years; and diabetes mellitus was no longer considered an exclusion criterion. All of these protocol modifications were extensively debated by the research team enrolled in the design, recruitment and conduction of the clinical trial to guarantee a high scientific quality. TRIAL REGISTRATION: Clinical Trials.gov, NCT00875173 . Registered on 20 October 2008.
引用
- Holanda MT, Mediano MFF, Hasslocher-Moreno AM, et al. A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial. Trials. 2018. PMID: 30231899. doi:10.1186/s13063-018-2889-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。